SERB
Location
ILE DE FRANCE
Founded
1951-07-25
Website
Risk Signals
32 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SERB
Live alerts from global media, monitored by Business Radar
2020-12-01 (massdevice.com)
Boston Scientific to sell BTG Specialty Pharmaceuticals for $800M
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to sell its BTG Specialty Pharmaceuticals business.
Read more
2018-06-15 (contractpharma.com)
Recipharm, SERB Enter Agreement |
For a divestment of its rights to its potassium iodide product ThyroSafe® except for the US territory.
Read more